Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 2020 | MRNA | Sale | 241,000 | $58.30 | $14.1M |
| May 27, 2020 | MRNA | Sale | 241,000 | $51.13 | $12.3M |
| May 18, 2020 | MRNA | Sale | 3,768 | $76.45 | $288K |
| May 18, 2020 | MRNA | Sale | 35,569 | $80.24 | $2.9M |
| May 18, 2020 | MRNA | Sale | 16,736 | $81.43 | $1.4M |
| May 18, 2020 | MRNA | Sale | 56,379 | $82.28 | $4.6M |
| May 18, 2020 | MRNA | Sale | 59,175 | $83.33 | $4.9M |
| May 18, 2020 | MRNA | Sale | 33,792 | $84.27 | $2.8M |
| May 18, 2020 | MRNA | Sale | 5,868 | $85.16 | $500K |
| May 18, 2020 | MRNA | Sale | 2,600 | $86.54 | $225K |
| May 18, 2020 | MRNA | Sale | 798 | $86.96 | $69K |
| May 18, 2020 | MRNA | Sale | 18,675 | $79.40 | $1.5M |
| May 18, 2020 | MRNA | Sale | 7,640 | $77.48 | $592K |
| May 15, 2020 | MRNA | Sale | 2,600 | $63.80 | $166K |
| May 15, 2020 | MRNA | Sale | 5,442 | $64.96 | $354K |
| May 15, 2020 | MRNA | Sale | 9,715 | $66.05 | $642K |
| May 15, 2020 | MRNA | Sale | 2,243 | $66.68 | $150K |
| May 12, 2020 | MRNA | Sale | 35,182 | $62.56 | $2.2M |
| May 12, 2020 | MRNA | Sale | 5,677 | $66.43 | $377K |
| May 12, 2020 | MRNA | Sale | 2,237 | $67.32 | $151K |
| May 12, 2020 | MRNA | Sale | 31,948 | $63.57 | $2.0M |
| May 12, 2020 | MRNA | Sale | 104,544 | $64.67 | $6.8M |
| May 12, 2020 | MRNA | Sale | 61,412 | $65.47 | $4.0M |
| Apr 15, 2020 | MRNA | Sale | 6,177 | $34.24 | $212K |
| Apr 15, 2020 | MRNA | Sale | 400 | $38.24 | $15K |
| Apr 15, 2020 | MRNA | Sale | 7,340 | $37.62 | $276K |
| Apr 15, 2020 | MRNA | Sale | 4,566 | $36.57 | $167K |
| Apr 15, 2020 | MRNA | Sale | 1,517 | $35.81 | $54K |
| Mar 16, 2020 | MRNA | Sale | 1,134 | $27.39 | $31K |
| Mar 16, 2020 | MRNA | Sale | 9,370 | $26.74 | $251K |
| Mar 16, 2020 | MRNA | Sale | 6,704 | $25.85 | $173K |
| Mar 16, 2020 | MRNA | Sale | 2,792 | $24.68 | $69K |
| Mar 4, 2020 | MRNA | Sale | 20,000 | $27.71 | $554K |
| Feb 26, 2020 | MRNA | Sale | 12,819 | $28.79 | $369K |
| Feb 26, 2020 | MRNA | Sale | 5,088 | $27.96 | $142K |
| Feb 26, 2020 | MRNA | Sale | 745 | $29.46 | $22K |
| Feb 25, 2020 | MRNA | Sale | 100 | $26.14 | $3K |
| Feb 25, 2020 | MRNA | Sale | 1,248 | $25.59 | $32K |
| Feb 7, 2020 | MRNA | Sale | 33,295 | $23.06 | $768K |
| Jan 28, 2020 | MRNA | Sale | 900 | $23.37 | $21K |
| Jan 27, 2020 | MRNA | Sale | 23,805 | $23.01 | $548K |
| Jan 22, 2020 | MRNA | Sale | 2,000 | $23.04 | $46K |
| Dec 6, 2019 | MRNA | Sale | 1,306 | $20.93 | $27K |
| Dec 6, 2019 | MRNA | Sale | 147,528 | $20.39 | $3.0M |
| Dec 6, 2019 | MRNA | Sale | 89,698 | $19.34 | $1.7M |
SEC reporting-owner ID (CIK) 1643746 · all filings on EDGAR